Technology
A team has created potential synthetic cells, sparking debate over their life-like properties and implications for biological engineering.
Technology
Anthropic launches Claude Science to aid pharmaceutical research, while Trump's drug pricing plans face hurdles with mid-sized companies.
Technology
Zyn's nicotine pouch marketing is approved by the FDA, claiming lower risks compared to cigarettes, prompting concern among health advocates.
Technology
Orca Bio receives FDA approval for Tregzi, a personalized T-cell therapy aimed at reducing complications in blood cancer patients undergoing transplants.
Technology
A recent revelation exposes the alcohol industry's significant financial influence on public health organizations, impacting cancer prevention messaging.
Finance
Current diagnostic strategies for Ebola and Marburg viruses fail to adapt to the complexities of overlapping outbreaks, highlighting urgent needs in public health.
Technology
The third quarter of 2026 promises significant biotech events, including critical trial results that could impact stock performance across the sector.
Technology
At BIO 2026, the mood was markedly more positive compared to previous events, showcasing a renewed energy in the biotech sector.
Technology
The 988 LGBTQ+ crisis hotline is set to relaunch, but concerns arise over the exclusion of The Trevor Project, pivotal in its original development.
Technology
New advancements in embryo editing highlight safety and efficacy but raise old ethical questions, making this a key topic for future discussions.
Technology
The European Commission is probing Sanofi for allegedly undermining a competitor's flu vaccine in its promotional activities.
Finance
While Richard Preston's "The Hot Zone" drew many to infectious diseases, it created lasting misconceptions about Ebola that still persist today.
Technology
Jails face challenges in managing severe withdrawal symptoms from fentanyl laced with medetomidine, highlighting critical gaps in treatment.
Technology
A patient with pulmonary hypertension received Eli Lilly's unapproved obesity drug under compassionate use, sparking interest in its potential effects.
Technology
Joseph Fraumeni Jr. dedicated his life to cancer research, significantly transforming the understanding of hereditary cancers and helping countless families.